Compare Enveric Biosciences Inc (ENVB) vs iShares Core MSCI Emerging Markets ETF (IEMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs iShares Core MSCI Emerging Markets ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while iShares Core MSCI Emerging Markets ETF trades at $81.24. The key difference: iShares Core MSCI Emerging Markets ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | IEMG | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $17.40 | $86.00 |
52-Week Low | $1.27 | $61.76 |
Enterprise Value | $1.30M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →
